| Item Type | Name |
|
Concept
|
Head and Neck Neoplasms
|
|
Academic Article
|
Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease.
|
|
Academic Article
|
Continuous infusion paclitaxel, 5-fluorouracil, and hydroxyurea with concomitant radiotherapy in patients with advanced or recurrent head and neck cancer.
|
|
Academic Article
|
Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
|
|
Academic Article
|
Head and neck cancer.
|
|
Academic Article
|
Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis.
|
|
Academic Article
|
DNA double-strand break rejoining rates, inherent radiation sensitivity and human tumour response to radiotherapy.
|
|
Academic Article
|
Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer.
|
|
Academic Article
|
Perspectives on combination chemotherapy with concomitant radiotherapy for poor-prognosis head and neck cancer.
|
|
Academic Article
|
Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer.
|
|
Academic Article
|
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck.
|
|
Academic Article
|
Modulation of apoptotic response of a radiation-resistant human carcinoma by Pseudomonas exotoxin-chimeric protein.
|
|
Academic Article
|
Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival.
|
|
Academic Article
|
The interaction of 5-fluorouracil, hydroxyurea, and radiation in two human head and neck cancer cell lines.
|
|
Academic Article
|
The contribution of DNA ploidy to radiation sensitivity in human tumour cell lines.
|
|
Academic Article
|
Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: a feasible and active approach.
|
|
Academic Article
|
Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer.
|
|
Academic Article
|
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.
|
|
Academic Article
|
Concomitant chemoradiotherapy with cisplatin, 5-fluorouracil and hydroxyurea in poor-prognosis head and neck cancer.
|
|
Academic Article
|
Cytogenetic evidence of the multistep origin of head and neck squamous cell carcinomas.
|
|
Academic Article
|
Volumetric visualization of head and neck CT data for treatment planning.
|
|
Academic Article
|
Treatment of head and neck and esophageal xenografts employing Alimta and concurrent ionizing radiation.
|
|
Academic Article
|
In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivo.
|
|
Academic Article
|
Paclitaxel, 5-fluorouracil, hydroxyurea, and concomitant radiation therapy for poor-prognosis head and neck cancer.
|
|
Academic Article
|
5-Fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study.
|
|
Academic Article
|
The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection.
|
|
Academic Article
|
Hydroxyurea with concomitant radiotherapy for locally advanced head and neck cancer.
|
|
Academic Article
|
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.
|
|
Academic Article
|
Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis.
|
|
Academic Article
|
Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer.
|
|
Academic Article
|
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
|
|
Academic Article
|
Prognostic factors in advanced head and neck cancer patients undergoing multimodality therapy.
|
|
Academic Article
|
Radiotherapy with concomitant chemotherapy for head and neck cancer.
|
|
Academic Article
|
Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.
|
|
Academic Article
|
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.
|
|
Academic Article
|
Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors.
|
|
Academic Article
|
Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institution.
|
|
Academic Article
|
Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
|
|
Academic Article
|
Recent advances in radiation therapy for head and neck cancer.
|
|
Academic Article
|
More on cetuximab in head and neck cancer.
|
|
Academic Article
|
Prediction of the radiation sensitivity of human squamous cell carcinoma cells using DNA filter elution.
|
|
Academic Article
|
Initial adjuvant therapy in advanced squamous cell carcinoma of the head and neck employing weekly high dose methotrexate with leucovorin rescue.
|
|
Academic Article
|
Variation in radiation sensitivity during the cell cycle of two human squamous cell carcinomas.
|
|
Academic Article
|
Initial adjuvant weekly high dose methotrexate with leucovorin rescue in advanced squamous carcinoma of the head and neck.
|
|
Academic Article
|
Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer.
|
|
Academic Article
|
Predefinitive and postdefinitive chemotherapy for locally advanced squamous carcinoma of the head and neck.
|
|
Academic Article
|
Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers.
|
|
Academic Article
|
An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck.
|
|
Academic Article
|
A randomized study comparing two regimens of neoadjuvant and adjuvant chemotherapy in multimodal therapy for locally advanced head and neck cancer.
|
|
Academic Article
|
Platinum complexes inhibit repair of potentially lethal damage following bleomycin treatment.
|
|
Academic Article
|
Vascular events in patients receiving high-dose infusional 5-fluorouracil-based chemotherapy: the University of Chicago experience.
|
|
Academic Article
|
A randomized study of inpatient versus outpatient continuous intravenous infusion chemotherapy: psychosocial aspects.
|
|
Academic Article
|
Radioresistant tumor cell lines derived from head and neck radiation failures.
|
|
Academic Article
|
Southern analysis of human head and neck cancer cells for homologous sequences using yeast gamma repair genes.
|
|
Academic Article
|
Epidermal growth factor receptor gene amplification and expression in head and neck cancer cell lines.
|
|
Academic Article
|
Concomitant hydroxyurea, 5-fluorouracil, and radiation therapy for recurrent head and neck cancer: early results.
|
|
Academic Article
|
Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy.
|
|
Academic Article
|
The syndrome of inappropriate antidiuretic hormone secretion associated with induction chemotherapy for squamous cell carcinoma of the head and neck.
|
|
Academic Article
|
Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer.
|
|
Academic Article
|
Cellular X-ray repair parameters of early passage squamous cell carcinoma lines derived from patients with known responses to radiotherapy.
|
|
Academic Article
|
Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neck.
|
|
Academic Article
|
Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer.
|
|
Academic Article
|
Multidisciplinary treatment of advanced squamous carcinoma of the head and neck.
|
|
Academic Article
|
Predictors of competing mortality in advanced head and neck cancer.
|
|
Academic Article
|
A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer.
|
|
Academic Article
|
Combined modality treatment of head and neck cancer with cisplatin, bleomycin, methotrexate-leucovorin chemotherapy.
|
|
Academic Article
|
Neoadjuvant and adjuvant methotrexate, cisplatin, and fluorouracil in multimodal therapy of head and neck cancer.
|
|
Academic Article
|
Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM).
|
|
Academic Article
|
Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients.
|
|
Academic Article
|
Incidence of hypothyroidism following multimodality treatment for advanced squamous cell cancer of the head and neck.
|
|
Academic Article
|
Increased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate-leucovorin in patients with advanced squamous carcinoma of the head and neck: a safe new effective regimen.
|
|
Academic Article
|
The differential diagnosis of the mass in the neck. A fresh look.
|
|
Academic Article
|
Efficacy of the multi-kinase inhibitor enzastaurin is dependent on cellular signaling context.
|
|
Academic Article
|
Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer.
|
|
Academic Article
|
Chromosome changes characterizing in vitro response to radiation in human squamous cell carcinoma lines.
|
|
Academic Article
|
Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study.
|
|
Academic Article
|
Toxicity of aggressive multimodality therapy including cisplatinum, bleomycin and methotrexate with radiation and/or surgery for advanced head and neck cancer.
|
|
Academic Article
|
Improved survival for patients with advanced carcinoma of the head and neck treated with methotrexate-leucovorin prior to definitive radiotherapy or surgery.
|
|
Academic Article
|
The role of paclitaxel in the treatment of head and neck cancer.
|
|
Academic Article
|
Chemical modulation of the hypoxic fraction in the treatment of head and neck cancer.
|
|
Academic Article
|
Radiobiologic research for head and neck cancer therapy. Therapeutic implications.
|
|
Academic Article
|
Measurable impact: multimodality therapy of head and neck cancer.
|
|
Academic Article
|
Hydroxyurea with continuous infusion paclitaxel, 5-fluorouracil, and concomitant radiotherapy for poor-prognosis head and neck cancer.
|
|
Academic Article
|
Surgical management of the head and neck cancer patient following concomitant multimodality therapy.
|
|
Academic Article
|
Radiation therapy in head and neck cancer: indications and limitations.
|
|
Academic Article
|
Radiobiological characterization of head and neck and sarcoma cells derived from patients prior to radiotherapy.
|
|
Academic Article
|
Advanced squamous carcinoma of the head and neck. A preliminary report of neoadjuvant chemotherapy with cisplatin, bleomycin, and methotrexate.
|
|
Academic Article
|
Chemotherapy for advanced carcinoma of the head and neck. A clinical update.
|
|
Academic Article
|
Combined modality therapy of head and neck cancer.
|
|
Academic Article
|
Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.
|
|
Academic Article
|
Swallowing function in patients with head and neck cancer prior to treatment.
|
|
Academic Article
|
Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer.
|
|
Academic Article
|
Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
|
|
Academic Article
|
Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis.
|
|
Academic Article
|
Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer.
|
|
Academic Article
|
Sequential administration of methotrexate, cisplatin, and 5-fluorouracil in multimodal therapy for locally advanced head and neck cancer.
|
|
Academic Article
|
Role of chemotherapy in the multidisciplinary approach to advanced head and neck cancer: potentials and problems.
|
|
Academic Article
|
Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer.
|
|
Academic Article
|
p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines.
|
|
Academic Article
|
A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.
|
|
Academic Article
|
Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
|
|
Academic Article
|
Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes.
|
|
Academic Article
|
DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer.
|
|
Academic Article
|
Race and competing mortality in advanced head and neck cancer.
|
|
Academic Article
|
Poly (ADP-ribose) polymerase inhibitor efficacy in head and neck cancer.
|
|
Academic Article
|
Comparison of carboplatin-paclitaxel to docetaxel-cisplatin-5-flurouracil induction chemotherapy followed by concurrent chemoradiation for locally advanced head and neck cancer.
|
|
Academic Article
|
Effect of postradiotherapy neck dissection on nonregional disease sites.
|
|
Academic Article
|
Comparison of 3D confromal radiotherapy and intensity modulated radiotherapy with or without simultaneous integrated boost during concurrent chemoradiation for locally advanced head and neck cancers.
|
|
Academic Article
|
Racial parities in outcomes after radiotherapy for head and neck cancer.
|
|
Academic Article
|
Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinoma.
|
|
Academic Article
|
Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer.
|